These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31096638)

  • 1. Bone Morphogenetic Protein-8B Expression is Induced in Steatotic Hepatocytes and Promotes Hepatic Steatosis and Inflammation In Vitro.
    Mahli A; Seitz T; Beckröge T; Freese K; Thasler WE; Benkert M; Dietrich P; Weiskirchen R; Bosserhoff A; Hellerbrand C
    Cells; 2019 May; 8(5):. PubMed ID: 31096638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
    Arndt S; Wacker E; Dorn C; Koch A; Saugspier M; Thasler WE; Hartmann A; Bosserhoff AK; Hellerbrand C
    Gut; 2015 Jun; 64(6):973-81. PubMed ID: 25011936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulatory bone morphogenetic protein (BMP) 8B is a non-invasive predictive biomarker for the diagnosis of non-alcoholic steatohepatitis (NASH).
    Mounika N; Yadav A; Kamboj P; Banerjee SK; Deka UJ; Kaur S; Adela R
    PLoS One; 2023; 18(12):e0295839. PubMed ID: 38127951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis.
    Vacca M; Leslie J; Virtue S; Lam BYH; Govaere O; Tiniakos D; Snow S; Davies S; Petkevicius K; Tong Z; Peirce V; Nielsen MJ; Ament Z; Li W; Kostrzewski T; Leeming DJ; Ratziu V; Allison MED; Anstee QM; Griffin JL; Oakley F; Vidal-Puig A
    Nat Metab; 2020 Jun; 2(6):514-531. PubMed ID: 32694734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD.
    Patton A; Church T; Wilson C; Thuma J; Goetz DJ; Berryman DE; List EO; Schwartz F; McCall KD
    J Endocrinol; 2018 Jun; 237(3):337-351. PubMed ID: 29666152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
    Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iso-alpha acids from hops (Humulus lupulus) inhibit hepatic steatosis, inflammation, and fibrosis.
    Mahli A; Koch A; Fresse K; Schiergens T; Thasler WE; Schönberger C; Bergheim I; Bosserhoff A; Hellerbrand C
    Lab Invest; 2018 Dec; 98(12):1614-1626. PubMed ID: 30089858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXC Motif Ligand 16 Promotes Nonalcoholic Fatty Liver Disease Progression via Hepatocyte-Stellate Cell Crosstalk.
    Jiang L; Yang M; Li X; Wang Y; Zhou G; Zhao J
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3974-3985. PubMed ID: 30053055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
    Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
    J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis.
    Serrano-Maciá M; Simón J; González-Rellan MJ; Azkargorta M; Goikoetxea-Usandizaga N; Lopitz-Otsoa F; De Urturi DS; Rodríguez-Agudo R; Lachiondo-Ortega S; Mercado-Gomez M; Gutiérrez de Juan V; Bizkarguenaga M; Fernández-Ramos D; Buque X; Baselli GA; Valenti LVC; Iruzubieta P; Crespo J; Villa E; Banales JM; Avila MA; Marin JJG; Aspichueta P; Sutherland J; Barrio R; Mayor U; Elortza F; Xirodimas DP; Nogueiras R; Delgado TC; Martínez-Chantar ML
    Mol Metab; 2021 Nov; 53():101275. PubMed ID: 34153521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
    Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The marine compound and elongation factor 1A1 inhibitor, didemnin B, provides benefit in western diet-induced non-alcoholic fatty liver disease.
    Wilson RB; Chen YJ; Sutherland BG; Sawyez CG; Zhang R; Woolnough T; Hetherington AM; Peters KM; Patel K; Kennelly JP; Leonard KA; Schuurman M; Jacobs RL; Wang R; Borradaile NM
    Pharmacol Res; 2020 Nov; 161():105208. PubMed ID: 32977024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation.
    Wu X; Zheng H; Yang R; Luan X; Zhang L; Jin Q; Jin Y; Xue J
    Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E436-E445. PubMed ID: 31211621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hop-derived Humulinones Reveal Protective Effects in in vitro Models of Hepatic Steatosis, Inflammation and Fibrosis.
    Mahli A; Thasler WE; Biendl M; Hellerbrand C
    Planta Med; 2023 Oct; 89(12):1138-1146. PubMed ID: 37343573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
    Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
    PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Chi X; Qu N; Wang C
    Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.